UBS Group
HWELW

UBS Group’s Healthwell Acquisition Corp. I Warrant HWELW Stock Holding History

UBS Group’s Portfolio HWELW Stock Details HWELW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,502
Closed -$425 – 10377
2023
Q3 		$425 Buy
+2,502
New +$573 ﹤0.01% 8503

UBS Group's HWELW Position: Q4 2023 in Review

UBS Group sold out of Healthwell Acquisition Corp. I Warrant (HWELW) in Q4 2023, closing a stake of 2,502 shares — an estimated $425 sold.

UBS Group first reported a position in HWELW in Q3 2023 and held it in 1 quarter. The position peaked at $425 in Q3 2023. 0 funds tracked by Wall St. Rank hold HWELW as of Q4 2023.

  • UBS Group reported no remaining Healthwell Acquisition Corp. I Warrant position as of Q4 2023 after selling out during the quarter.
  • UBS Group sold 2,502 Healthwell Acquisition Corp. I Warrant shares in Q4 2023, an estimated $425.
  • UBS Group first reported a position in Healthwell Acquisition Corp. I Warrant in Q3 2023 and held it in 1 quarter.
  • UBS Group's Healthwell Acquisition Corp. I Warrant position peaked at $425 in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Healthwell Acquisition Corp. I Warrant as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.